Stock Information
Entrada Therapeutics Inc (TRDA)
Ticker Symbol: TRDA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $455.96 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -2.5032
Revenue (TTM): $1.48 M
Dividend Yield: N/A%
ROE: -26.42%
Latest News
-
Earnings Summary: Entrada Therapeutics Q4
Thu, Feb 26, 2026 8:26 AM
-
Entrada Therapeutics Q4 EPS $(0.94) Beats $(1.07) Estimate, Sales $1.299M Miss $13.886M Estimate
Thu, Feb 26, 2026 8:25 AM
Key Financials
Financial data not available